Bakhu Holdings, CORP

Bakhu Holdings Corp. announces new funding and governance agreements with Phytocyte Pty Ltd. and Inter-M Traders FZ-LLE to restore regulatory compliance.

Bakhu Holdings, Corp. reports the resignation of its independent auditor due to a PCAOB inquiry and the subsequent delay in filing its annual report.

Bakhu Holdings has announced the appointment of Mitch Kahn as Chair of the Board and Dr. Teddy Scott as President and CEO, effective April 10, 2024.

Bakhu Holdings closed the first tranche of a private placement, raising $1.03 million, while also restructuring its board and extending debt maturities.

Bakhu Holdings reports no revenue for Q3 2024, a net loss of $906,837, and ongoing efforts to secure additional funding while addressing significant liabilities.

Bakhu Holdings reports a net loss of $1.25 million for the six months ended January 31, 2024, while securing $1.03 million in financing and expanding its board of directors.

Bakhu Holdings, Corp. reported its financial results for the first quarter of fiscal year 2024, showing no revenue and a net loss, while continuing efforts to commercialize its licensed cannabis technology.

Bakhu Holdings Corp. files its Form 10-K for the fiscal year ended July 31, 2024, detailing significant financial challenges, ongoing efforts to secure funding, and operational suspensions.